“We're still studying it,” AbbVie CEO Robert Michael told investors at the conference, taking place this week in San Francisco. “We still think emraclidine can play a role.” If AbbVie ...

As the J.P. Morgan Healthcare Conference started in San Francisco on Monday, AbbVie linked up with Simcere ... at building a sixth plant in Incheon, South Korea. The fifth plant will bring Samsung ...

the first day of the healthcare industry's top conference in San Francisco. Drugmakers rush to sign deals on first day of industry conference January 13, 2025 AbbVie has obtained the option to ...

Humira generated $187bn in revenues for AbbVie. Speaking at the JP Morgan Healthcare Conference 2025 in San Francisco, CEO Rob Michael said that despite the Humira pull back, only about 20% of ...